Business Description
Pila Pharma AB
ISIN : SE0015988274
Compare
Compare
Traded in other countries / regions
PILA.Sweden5KC.Germany IPO Date
2021-07-15Description
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.97 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 17.54 | |||||
Beneish M-Score | -5.63 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 1.2 | |||||
3-Year EPS without NRI Growth Rate | -13.1 | |||||
3-Year FCF Growth Rate | -22.9 | |||||
3-Year Book Growth Rate | 9.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.13 | |||||
9-Day RSI | 58.54 | |||||
14-Day RSI | 58.31 | |||||
6-1 Month Momentum % | 95.49 | |||||
12-1 Month Momentum % | 56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.48 | |||||
Quick Ratio | 3.48 | |||||
Cash Ratio | 3.32 | |||||
Days Sales Outstanding | 12.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.9 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -436.98 | |||||
Net Margin % | -678.74 | |||||
FCF Margin % | -331.78 | |||||
ROE % | -198.52 | |||||
ROA % | -147.46 | |||||
ROIC % | -155.99 | |||||
ROC (Joel Greenblatt) % | -989000 | |||||
ROCE % | -197.71 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 62.87 | |||||
PB Ratio | 16.18 | |||||
Price-to-Tangible-Book | 25.53 | |||||
EV-to-EBIT | -11.7 | |||||
EV-to-EBITDA | -13.14 | |||||
EV-to-Revenue | 79.11 | |||||
EV-to-FCF | -21.15 | |||||
Price-to-Net-Current-Asset-Value | 25.53 | |||||
Price-to-Net-Cash | 28.53 | |||||
Earnings Yield (Greenblatt) % | -8.54 | |||||
FCF Yield % | -4.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pila Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 1.463 | ||
EPS (TTM) (kr) | -0.47 | ||
Beta | 0 | ||
Volatility % | 114.27 | ||
14-Day RSI | 58.31 | ||
14-Day ATR (kr) | 0.729997 | ||
20-Day SMA (kr) | 4.6455 | ||
12-1 Month Momentum % | 56 | ||
52-Week Range (kr) | 0.992 - 8.44 | ||
Shares Outstanding (Mil) | 23.79 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pila Pharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pila Pharma AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Pila Pharma AB Frequently Asked Questions
What is Pila Pharma AB(OSTO:PILA)'s stock price today?
The current price of OSTO:PILA is kr4.85. The 52 week high of OSTO:PILA is kr8.44 and 52 week low is kr0.99.
When is next earnings date of Pila Pharma AB(OSTO:PILA)?
The next earnings date of Pila Pharma AB(OSTO:PILA) is 2024-08-27.
Does Pila Pharma AB(OSTO:PILA) pay dividends? If so, how much?
Pila Pharma AB(OSTO:PILA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |